Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians can combine, mix, or adjust the ingredients of a medication — to meet ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...